نتایج جستجو برای: t cell vaccination

تعداد نتایج: 2220123  

Journal: :Infection and immunity 1998
L M Naess F Oftung A Aase L M Wetzler R Sandin T E Michaelsen

We have analyzed human T-cell responses in parallel with serum immunoglobulin G (IgG) antibody levels after systemic vaccination with the Norwegian group B Neisseria meningitidis outer membrane vesicle (OMV) vaccine. Ten adult volunteers, with no or very low levels of serum IgG antibodies against meningococci, received three doses intramuscularly of the OMV vaccine (at weeks 0, 6, and 46). T-ce...

Journal: :The Journal of infectious diseases 2013
Joseph P Casazza Kathryn A Bowman Selorm Adzaku Emily C Smith Mary E Enama Robert T Bailer David A Price Emma Gostick Ingelise J Gordon David R Ambrozak Martha C Nason Mario Roederer Charla A Andrews Frank M Maldarelli Ann Wiegand Mary F Kearney Deborah Persaud Carrie Ziemniak Raphael Gottardo Julie E Ledgerwood Barney S Graham Richard A Koup

BACKGROUND The licensing of herpes zoster vaccine has demonstrated that therapeutic vaccination can help control chronic viral infection. Unfortunately, human trials of immunodeficiency virus (HIV) vaccine have shown only marginal efficacy. METHODS In this double-blind study, 17 HIV-infected individuals with viral loads of <50 copies/mL and CD4(+) T-cell counts of >350 cells/µL were randomly ...

Journal: :Clinical and vaccine immunology : CVI 2012
Rose-Minke Schure Lotte H Hendrikx Lia G H de Rond Kemal Oztürk Elisabeth A M Sanders Guy A M Berbers Anne-Marie Buisman

Immunization with acellular pertussis vaccine (aP) induces higher specific antibody levels and fewer adverse reactions than does immunization with the whole-cell vaccine (wP). However, antibody levels in infants induced by both types of pertussis vaccines wane already after 1 year. Therefore, long-term T-cell responses upon vaccination might play a role in protection against pertussis. In a cro...

Journal: :Journal of immunology 2003
Tonia Woodberry Joy Gardner Suzanne L Elliott Sonja Leyrer David M Purdie Paul Chaplin Andreas Suhrbier

Vaccination strategies involving priming with DNA and boosting with a poxvirus vector have emerged as a preferred combination for the induction of protective CD8 T cell immunity. Using IFN-gamma ELISPOT and a series of DNA plasmid, peptide, and modified vaccinia Ankara (MVA) vaccine combinations, we demonstrate that the DNA/MVA combination was uniquely able to enhance IFN-gamma secretion by Ag-...

Journal: :The Journal of infectious diseases 2012
Robert J Snelgrove Megan M Cornere Lorna Edwards Belinda Dagg James Keeble Angela Rodgers Daphne E Lyonga Graham R Stewart Douglas B Young Barry Walker Tracy Hussell

Mycobacterium tuberculosis infection claims approximately 2 million lives per year, and improved efficacy of the BCG vaccine remains a World Health Organization priority. Successful vaccination against M. tuberculosis requires the induction and maintenance of T cells. Targeting molecules that promote T-cell survival may therefore provide an alternative strategy to classic adjuvants. We show tha...

Journal: :Cell reports 2016
Pavlo Gilchuk Timothy M Hill Clifford Guy Sean R McMaster Kelli L Boyd Whitney A Rabacal Pengcheng Lu Yu Shyr Jacob E Kohlmeier Eric Sebzda Douglas R Green Sebastian Joyce

The nature and anatomic location of the protective memory CD8(+) T cell subset induced by intranasal vaccination remain poorly understood. We developed a vaccination model to assess the anatomic location of protective memory CD8(+) T cells and their role in lower airway infections. Memory CD8(+) T cells elicited by local intranasal, but not systemic, vaccination with an engineered non-replicati...

Journal: :PLoS Pathogens 2008
Karen A. Chachu Anna D. LoBue David W. Strong Ralph S. Baric Herbert W. Virgin

Two cardinal manifestations of viral immunity are efficient clearance of acute infection and the capacity to vaccinate against secondary viral exposure. For noroviruses, the contributions of T cells to viral clearance and vaccination have not been elucidated. We report here that both CD4 and CD8 T cells are required for efficient clearance of primary murine norovirus (MNV) infection from the in...

2012
Lindsay R. Ancelet Frank E. Aldwell Fenella J. Rich Joanna R. Kirman

Oral delivery of BCG in a lipid formulation (Liporale™-BCG) targets delivery of viable bacilli to the mesenteric lymph nodes and confers protection against an aerosol Mycobacterium tuberculosis challenge. The magnitude, quality and duration of the effector and memory immune response induced by Liporale™-BCG vaccination is unknown. Therefore, we compared the effector and memory CD4(+) T cell res...

Journal: :Infection and immunity 1996
F Zepp M Knuf P Habermehl J H Schmitt C Rebsch P Schmidtke R Clemens M Slaoui

The aim of this study was to investigate pertussis-specific cell-mediated immunity in infants vaccinated with a tricomponent acellular vaccine. Infants were investigated during a primary vaccination schedule from the third month of life to the sixth month as well as before and after a booster at 15 to 24 months. This is the first report of specific cell-mediated immune responses to pertussis-re...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید